article thumbnail

Jupiter Neurosciences Makes Way in CNS Treatments with $11M IPO

XTalks

Jotrol overcomes these barriers using patented micellar technology, enhancing bioavailability and enabling therapeutically effective doses. Conventional resveratrol products often face challenges like poor absorption and significant gastrointestinal side effects.

article thumbnail

Gelteq IPO: Supporting Gel Technology for Oral Drug Delivery

XTalks

The stable gel matrix holds multiple ingredients, offering targeted release and enhanced bioavailability while optimizing patient experience. Gelteq centers its technology on a proprietary, customizable gel platform designed for precise drug delivery, supporting prescription drugs, nutraceuticals, pet care and sports supplements.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

PureTech Reveals New CBD Pill to Rival Jazz’s Epidiolex

XTalks

Clinical-stage biotech company PureTech Health has announced it has developed a new oral CBD therapeutic candidate with improved bioavailability and tolerability, which could expand use of the CBD prodrug in a wide range of indications and age groups.

article thumbnail

Obesity-Focused Metsera Launches IPO Amid Much Anticipation

XTalks

The HALO platform enhances peptide half-life, facilitating monthly dosing and titration-free regimens, while the MOMENTUM platform optimizes oral bioavailability. Metseras HALO platform and MOMENTUM oral peptide delivery platform were used to develop these candidates. billion in 2024 to $37.94

article thumbnail

Expert Insights: Development and Manufacture of Highly Potent Oral Liquids

XTalks

Improved bioavailability can lead to a faster onset of therapeutic effects, which is especially valuable in conditions where prompt action is required. Advanced formulation techniques are often required to improve the solubility and bioavailability of these APIs. Dosing flexibility is another prominent advantage provided by PDFs.

article thumbnail

How Difficult Is it to Scale Up an Amorphous Dispersion?

XTalks

Therefore, techniques and technologies that promote drug solubility and bioavailability are in high demand. Their focus is on improving drug solubility and bioavailability with powerful amorphous dispersion technologies, such as KinetiSol for poorly soluble compounds.

article thumbnail

Cybin Announces First Quarter Financial Results of Clarmin Explorations Inc.

The Pharma Data

NEO:CYBN ) (“ Cybin ”), a life sciences company focused on psychedelic pharmaceutical therapies, announces the unaudited financial results of Clarmin Explorations Inc. Cybin is a life sciences company advancing psychedelic pharmaceutical treatments for various psychiatric and neurological conditions. 30, 2020 01:00 UTC.